Skip to content

Study · Measured the body's own peptide · 2017

1 result

MALDI MS imaging investigation of the host response to visceral leishmaniasis.

Jaegger CF, Negrão F, Assis DM, Belaz KRA, Angolini CFF, Fernandes AMAP, Santos VG, Pimentel A, Abánades DR, Giorgio S, Eberlin MN, Rocha DFO

Molecular bioSystems1 Sept 2017Cited by 9 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In the liver of mice infected with Leishmania infantum, the ion at m/z 4963, tentatively identified as Tβ4, was the most important for identifying acute infection.

    In plain wordsIn mice with leishmaniasis, a liver signal tentatively identified as the body's own thymosin beta‑4 best marked acute infection.

    Outcome
    Direction not reportedLiver ion m/z 4963 (tentatively Tβ4) in acute infection
    Study

    mousen: not reported in source

    Liver MALDI MSI in Balb/c mice infected with Leishmania infantum
    Outcome group
    Infection and antimicrobial activity · Infection

    Measurements

    ion m/z
    4963 m/z
    acute infection

    Source sentences

    Summary
    Among others, the ion of m/z 4963 was the most important to identify acute infection and was tentatively identified as Thymosin β4.
    1 context sentence
    Summary · context
    We analyzed liver sections of Balb/c mice infected with Leishmania infantum using the SCiLS Lab software for statistical analysis, which facilitated data interpretation and thus highlighted several key proteins and/or peptides.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.